AI assistant
NORTHROP GRUMMAN CORP /DE/ — Director's Dealing 2018
Feb 15, 2018
29899_dirs_2018-02-15_e32f3555-376f-4c7f-b4f1-9e82bd9d4981.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NORTHROP GRUMMAN CORP /DE/ (NOC)
CIK: 0001133421
Period of Report: 2018-02-13
Reporting Person: Warden Kathy J (President and COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-02-13 | Common Stock | M | 18939.0000 | $0.0000 | Acquired | 93276.3500 | Direct |
| 2018-02-13 | Common Stock | F | 8542.0000 | $0.0000 | Disposed | 84734.3500 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-13 | Restricted Performance Stock Rights | $ | A | 16257.0000 | Acquired | Common Stock (16257.0000) | Direct | |
| 2018-02-13 | Restricted Performance Stock Rights | $ | M | 18939.0000 | Disposed | Common Stock (18939.0000) | Direct | |
| 2018-02-13 | Restricted Stock Rights | $ | A | 4516.0000 | Acquired | Common Stock (4516.0000) | Direct |
Footnotes
F1: Shares expected to be issued in settlement of Restricted Performance Stock Rights ("RPSRs") granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/18/15 with a valuation of performance measurement period ("measurement period") that ended 12/31/17. RPSRs to be settled at 150% of target. The shares are anticipated to be distributed into the participant's account on February 22, 2018.
F2: Shares surrendered to issuer in payment of tax liability in connection with settlement of RPSRs in accordance with Rule 16b-3(e).
F3: Each RPSR represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the application performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d).
F4: The RPSRs acquired include (i) 6,313 vested RPSRs with respect to the measurement period ended 12/31/17 acquired due to settlement of the 2015 RPSRs held at 150% of the target award and (ii) 9,944 unvested RPSRs granted under the LTISP on 2/13/18 with a measurement period ending on 12/31/20.
F5: Total amount includes 18,939 vested RPSRs granted under the LTISP on 2/18/15 with a measurement period ended on 12/31/17; 9,944 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; 10,676 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19; and 12,710 RPSRs granted on 2/17/16 with a measurement period ending on 12/31/18.
F6: Total amount includes 9,944 RPSRs granted on 2/13/18 with a measurement period ending on 12/31/20; 10,676 RPSRs granted on 2/17/17 with a measurement period ending on 12/31/19; and 12,710 RPSRs granted on 2/17/16 with a measurement period ending on 12/31/18.
F7: Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the LTISP on 2/13/18 and will vest on 2/13/21.
F8: Total amount includes 4,516 RSRs granted under the LTISP on 2/13/18 that will vest on 2/13/21; 4,465 RSRs granted under the LTISP on 2/17/17 that will vest on 2/17/20; 5,767 RSRs granted under the LTISP on 2/17/16 that will vest on 2/17/19; and 5,954 RSRs granted under the LTISP on 2/18/15 that will vest on 2/18/18.